Citi Starts Puma Biotechnology (PBYI) at Buy
Tweet
Share
E-mailGet Alerts PBYI Hot Sheet
Price: $7.56 +4.56%
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Join SI Premium – FREE
Citi initiated coverage on Puma Biotechnology (NYSE: PBYI) with a Buy rating and a price target of $123.00.
For an analyst ratings summary and ratings history on Puma Biotechnology click here. For more ratings news on Puma Biotechnology click here.
Shares of Puma Biotechnology closed at $73.37 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ladenburg Thalmann Assumes Elicio Therapeutics (ELTX) at Buy Following Selloff, 'overblown'
- Goldman Sachs Starts Talen Energy (TLN) at Buy, PT $499, 'we see substantial incremental upside from potential additional PPA signings'
- Raymond James Starts Rexford Industrial Realty (REXR) at Underperform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
